1.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SFC-SV001, SFC-01-0150-0001-02-CM, SFC-01-0150-001, NCT00246727
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: SFC-SV002, NCT00246727
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007077-01H, NCT00668707
|
|
4.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H06-128, IND78,248, NCT00707252
|
|
5.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UMN-2008LS035, UMN-2008LS035, UMN-0803M29541, NCT00769990
|
|
6.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: UMCC 2008.042, HUM%21242, NCT00794547
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Mistletoe.ctil, NCT00516022
|
|
8.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 45 to 74
Sponsor: NCI
Protocol IDs: BCCA-H07-02401, H07-02401, NCT00611650
|
|
9.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 45 to 79
Sponsor: NCI
Protocol IDs: MAYO-MAY06-8-01, MAY06-8-01, NCT00783705
|
|
10.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CHNMC-07243, 07243, NCT00857025
|
|
11.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UPCC-03309, UPCC 03309, IRB# 806733, NCT00955942
|
|
12.
|
Phase: No phase specified
Type: Behavioral study, Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: #2000-007, NCI R03 CA88598-01A1, NCT00179348
|
|
13.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: 2004-064, NCT00444054
|
|
14.
|
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: Seigen Safety Trial: Cancer, WIRB Study No. 1085894, WIRB Pr. No. 20062258, NCT00606970
|
|
15.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08.0040, BCC-LUN-07-002, NCT00681512
|
|
16.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08.0041, BCC-LUN-07-005, NCT00682032
|
|
17.
|
Phase: No phase specified
Type: Educational/Counseling/Training, Supportive care
Status: Active
Age: Over 18
Sponsor: NCI
Protocol IDs: MGH-2007-P-000368, 2007-P-000368, NCT00706290
|
|
18.
|
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 to 86
Sponsor: Other
Protocol IDs: HP-00043968, NCT00780611
|
|
19.
|
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 07/Q1607/48, NCT00830921
|
|
20.
|
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCSU-001-CFS, NCT00851448
|
|
21.
|
Phase: No phase specified
Type: Diagnostic
Status: Approved-not yet active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 2010-no-emn, NCT00880945
|
|
22.
|
Phase: No phase specified
Type: Supportive care
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 0S-08-9, NCT00936364
|
